Ipca Laboratories Ltd.

BSE: 524494 | NSE: IPCALAB |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE571A01020 | SECTOR: PharmaceuticalsPharmaceuticals

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Ipca Laborator Ipca Laboratories Ltd. | BSE 2010.10 -5.10 (-0.25%) | NSE 2011.50 -4.30 (-0.21%) | Trade | Add

BSE Live

Dec 07, 15:44

2010.10 -5.10 (-0.25%)

Volume

AVERAGE VOLUME

5-Day

19,057

10-Day

20,746

30-Day

14,141

9,381

Prev. Close

2015.20
Open Price

2015.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2010.10 (31)

NSE Live

Dec 07, 15:45

2011.50 -4.30 (-0.21%)

Volume

AVERAGE VOLUME

5-Day

2,533,650

10-Day

1,764,269

30-Day

805,383

741,387

Prev. Close

2015.80
Open Price

2018.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
2011.50 (883)

Financials

Download Annual Report in PDF format 2020 2019 2018 2017 2016

Print/Copy to Excel : Go

Half Yearly Results of Ipca Laboratories (in Rs. Cr.)	Sep '21	Mar '21	Mar '20	Sep '19	Mar '19
Net Sales/Income from operations	2,902.44	2,356.14	2,143.86	2,223.57	1,781.40
Other Operating Income	--	--	--	--	--
Total Income From Operations	2,902.44	2,356.14	2,143.86	2,223.57	1,781.40
EXPENDITURE
Consumption of Raw Materials	808.50	787.02	721.69	709.41	560.32
Purchase of Traded Goods	109.79	131.53	104.83	99.82	84.84
Increase/Decrease in Stocks	56.05	-150.07	-118.05	-37.00	-76.48
Power & Fuel	--	--	--	--	--
Employees Cost	557.28	467.83	445.60	425.19	353.07
Depreciation	100.46	96.23	91.54	87.15	84.23
Excise Duty	--	--	--	--	--
Admin. And Selling Expenses	--	--	--	--	--
R & D Expenses	--	--	--	--	--
Provisions And Contingencies	--	--	--	--	--
Exp. Capitalised	--	--	--	--	--
Other Expenses	617.82	554.36	531.63	569.55	453.28
P/L Before Other	652.54	469.24	366.62	369.45	322.14
Other Income	28.68	35.56	30.93	33.76	27.21
P/L Before Int.	681.22	504.80	397.55	403.21	349.35
Interest	2.73	3.87	7.27	8.52	11.18
P/L Before Exceptional Items & Tax	678.49	500.93	390.28	394.69	338.17
Exceptional Items	--	--	--	--	--
P/L Before Tax	678.49	500.93	390.28	394.69	338.17
Tax	136.13	89.48	65.89	66.62	68.52
P/L After Tax from Ordinary Activities	542.36	411.45	324.39	328.07	269.65
Prior Year Adjustments	--	--	--	--	--
Extra Ordinary Items	--	--	--	--	--
Net Profit/(Loss) For the Period	542.36	411.45	324.39	328.07	269.65
Equity Share Capital	25.37	25.37	25.27	25.27	25.27
Reserves Excluding Revaluation Reserves	--	--	--	3,389.63	--
Equity Dividend Rate (%)	--	--	--	--	--
EPS Before Extra Ordinary
Basic EPS	42.76	32.44	25.67	25.96	--
Diluted EPS	42.76	--	--	25.96	--
EPS After Extra Ordinary
Basic EPS.	42.76	32.44	25.67	25.96	--
Diluted EPS.	42.76	--	--	25.96	--
Public Share Holding
No Of Shares (Crores)	--	--	--	--	--
Share Holding (%)	--	--	--	--	--
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)	--	--	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group)	--	--	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company)	--	--	--	--	--
b) Non-encumbered
- Number of shares (Crores).	--	--	--	--	--
- Per. of shares (as a % of the total sh. of prom. and promoter group).	--	--	--	--	--
- Per. of shares (as a % of the total Share Cap. of the company).	--	--	--	--	--